Consider alternant therapies that aren't average CYP3A inducers through cure with mitapivat. If not able to stay away from coadministration, check Hb and titrate past fifty mg BID, if vital, but will not exceed mitapivat dose of one hundred mg BID. .pentobarbital will lower the level or outcome of bortezomib by impacting hepatic/intestinal enzyme C